Author: digi

Case-Based Insights into Stability-Driven Shelf Life Reduction

Pharmaceutical shelf life isn’t just a number printed on the label—it’s a result of years of meticulous stability studies. However, even with robust protocols in place, shelf life reductions do occur. These are often triggered by unexpected degradation pathways, formulation weaknesses, or packaging failures. In this tutorial, we examine case-based insights where shelf life had…

Factors Affecting Drug Shelf Life (Storage Conditions, Container, Light, etc.), Shelf Life and Expiry

Photostability Testing: Monitoring Light Intensity and Exposure in Pharmaceuticals

Photostability testing plays a pivotal role in pharmaceutical product development and stability studies. It ensures that exposure to light does not compromise a drug’s safety, identity, strength, quality, or purity. According to ICH Q1B guidelines, light-sensitive drug products must undergo rigorous testing under controlled lighting conditions. This tutorial outlines how to effectively monitor light intensity…

Equipment and Calibration, Light, Humidity, and Temperature Monitoring in Stability

FDA Guidance on Data Integrity for Stability Testing

Data integrity continues to be a top concern in FDA inspections across pharmaceutical facilities. Especially in stability testing, where long-term data supports product shelf life and regulatory claims, ensuring reliable and traceable data is crucial. This article explores the FDA’s guidance on data integrity and how pharma professionals can align their stability testing operations to…

Best Practices for Stability Testing Data Integrity, Pharmaceutical Quality and Practices

SOP for Addressing Stability Testing for Drugs in Special Populations as per Regulatory Guidelines

SOP for Addressing Stability Testing for Drugs in Special Populations as per Regulatory Guidelines Procedure for Stability Testing of Drugs for Special Populations 1) Purpose The purpose of this SOP is to establish a procedure for conducting stability testing of drugs intended for special populations (e.g., pediatric, geriatric, pregnant women) in compliance with relevant regulatory…

Stability Studies SOP

CAPA Effectiveness Monitoring Tools for Stability Operations

💻 Introduction: Why CAPA Monitoring Tools Matter in Stability In the tightly regulated pharmaceutical industry, it’s not enough to just initiate corrective and preventive actions (CAPA) — you must prove they are effective. In stability operations, especially where temperature excursions or equipment deviations can jeopardize long-term data, effective CAPA monitoring ensures the integrity of your…

Handling Deviations and CAPA in Stability Reports, Protocols and Reports

Plan Comparative Stability Studies for Biosimilars vs. Reference Product

Understanding the Tip: Why comparative stability is crucial in biosimilar development: Unlike generics, biosimilars must demonstrate similarity to a reference biologic across quality, safety, and efficacy attributes—including degradation behavior. Comparative stability studies provide critical evidence that the biosimilar maintains quality over time in a manner equivalent to the reference. These studies help confirm that the…

Stability Study Tips

How to Extend Shelf Life via Formulation Modifications

Pharmaceutical shelf life is not merely a function of storage conditions—it begins with the formulation itself. A robust formulation can significantly delay degradation pathways and maintain drug efficacy over time. Whether you’re developing a new product or reformulating an existing one, certain formulation strategies can enhance stability and extend shelf life. This article explores how…

Factors Affecting Drug Shelf Life (Storage Conditions, Container, Light, etc.), Shelf Life and Expiry

Best Practices in Preventing Data Manipulation in Stability Testing

In pharmaceutical stability testing, data integrity is paramount—not just for regulatory compliance, but to ensure that patients receive safe and effective medications. One of the most critical threats to this integrity is data manipulation, whether accidental or deliberate. This article presents best practices to prevent such occurrences and maintain trust in your stability data. 📈…

Best Practices for Stability Testing Data Integrity, Pharmaceutical Quality and Practices

Lifecycle Management of Regional Stability Submissions

Pharmaceutical products are subject to continuous regulatory oversight, especially regarding their stability profiles. Once a product is approved, stability data must be updated, monitored, and submitted according to the requirements of regional authorities like the FDA, EMA, and ASEAN. This article outlines how to effectively manage the lifecycle of stability submissions across global markets to…

Regional Guidelines: FDA, EMA, ASEAN, TGA, Regulatory Guidelines

Regulatory Expectations for Excursion Trending and CAPA Effectiveness

In the pharmaceutical industry, recurring temperature or humidity excursions during stability studies signal not just isolated failures but potential systemic breakdowns. Regulators such as the USFDA, EMA, and WHO expect a proactive, trend-based approach to monitoring such incidents. Moreover, they demand a robust system to evaluate the effectiveness of Corrective and Preventive Actions (CAPA) linked…

Handling Deviations and CAPA in Stability Reports, Protocols and Reports